Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Centessa Pharmaceuticals ADR | CNTA | Nov 22, 2024 | 17.04 | -6.32 |
Centrais Electricas Brasileiras B ADR | EBR-B | Nov 22, 2024 | 6.72 | -0.74 |
Centrais Eletricas Brasileiras ADR | EBR | Nov 22, 2024 | 6.08 | +0.16 |
Central Garden & Pet | CENT | Nov 22, 2024 | 38.70 | +0.89 |
Central Garden & Pet A | CENTA | Nov 22, 2024 | 33.18 | +0.88 |
Central Pacific Financial | CPF | Nov 22, 2024 | 32.17 | +2.55 |
Central Plains Bancshares | CPBI | Nov 22, 2024 | 14.37 | -1.07 |
Central Puerto ADR | CEPU | Nov 22, 2024 | 13.89 | +0.29 |
Central Securities | CET | Nov 22, 2024 | 46.52 | -0.26 |
Centrus Energy A | LEU | Nov 22, 2024 | 86.85 | +8.70 |
Centuri Holdings | CTRI | Nov 22, 2024 | 20.79 | -2.21 |
Centurion Acquisition | ALFUU | Nov 22, 2024 | 10.27 | 0.00 |
Century Aluminium | CENX | Nov 22, 2024 | 22.48 | -0.55 |
Century Casinos | CNTY | Nov 22, 2024 | 4.39 | -0.68 |
Century Communities | CCS | Nov 22, 2024 | 88.69 | +1.66 |
Century Therapeutics | IPSC | Nov 22, 2024 | 1.21 | -2.42 |
Cepton | CPTN | Nov 22, 2024 | 3.12 | -0.32 |
Ceragon Networks | CRNT | Nov 22, 2024 | 3.70 | +14.55 |
Cerence | CRNC | Nov 22, 2024 | 7.20 | +23.50 |
CeriBell | CBLL | Nov 22, 2024 | 26.31 | 0.00 |
CERo Therapeutics | CERO | Nov 22, 2024 | 0.22 | -12.02 |
Certara | CERT | Nov 22, 2024 | 10.36 | +6.04 |
Cerus | CERS | Nov 22, 2024 | 1.79 | +7.19 |
CervoMed | CRVO | Nov 22, 2024 | 9.60 | +0.21 |
CEVA | CEVA | Nov 22, 2024 | 30.44 | +6.17 |
CF Acquisition VII A | CFFS | Nov 22, 2024 | 11.12 | -0.45 |
CF Bankshares | CFBK | Nov 22, 2024 | 27.38 | -2.06 |
CF Industries | CF | Nov 22, 2024 | 89.79 | -0.94 |
CFSB Bancorp | CFSB | Nov 22, 2024 | 6.80 | +1.19 |
CG Oncology | CGON | Nov 22, 2024 | 33.47 | +3.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.